Anakinra - NUB Antrag Historie
translation missing: de.nub_pepp_changes.public_info
NUB-PEPP Historie
translation missing: de.nub_pepp_changes.details_title
| Jahr | translation missing: de.activerecord.attributes.nub_pepp_change_detail.inek_status | translation missing: de.activerecord.attributes.nub_pepp_change_detail.inek_clinic_cnt | translation missing: de.activerecord.attributes.nub_pepp_change_detail.inek_id | translation missing: de.activerecord.attributes.nub_pepp_change_detail.inek_comment | |
|---|---|---|---|---|---|
| 2021 | ** | ** | ** | ** | ** |
| 2020 | ** | ** | ** | ** | ** |
NUB-PEPP Anfragen in der NUB Börse
|
Anakinra
Anakinra ist ein humaner Interleukin-1 (IL-1)-Rezeptorantagonist. Es neutralisiert die biologische Aktivität von Interleu... |
2021 |